The Pfizer vaccine was developed in partnership with BioNTech, a German startup founded by Turkish immigrants. Media reports have framed this collaboration as a success story for globalization and a testament to international cooperation against a borderless disease. The narrative emphasizes the diverse origins of the scientists behind the first widely authorized mRNA vaccine.




